Trial Profile
A efficacy, safety and feasibility study of levodopa/carbidopa intestinal gel (LCIG) in patients with advanced parkinson's disease.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 16 Dec 2015 New trial record